Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variantShuai Xia, Shibo Jiang, Jasper Fuk‐Woo Chan et al.|Cell Research|2022Cited by 40
The image of genotyping result for rs7903146.Hu Dongsheng, Luo Xinping, Dahai Yu et al.|Figshare|2015Cited by 0